Pfizer Inc. (@pfizer) / X

Pfizer Inc.

11.4K posts

Pfizer Inc.

@pfizer

We’re celebrating over 175 years of daring scientific innovation and we’re not done yet. Protect your health at PfizerForAll.com on.pfizer.com/CGs

New York, NY

Joined July 2009

Pfizer Inc.
@pfizer
Nov 9, 2020
UPDATE: We are proud to announce, along with @BioNTech_Group, that our mRNA-based #vaccine candidate has, at an interim analysis, demonstrated initial evidence of efficacy against #COVID19 in participants without prior evidence of SARS-CoV-2 infection.
00:00
First Primary Efficacy Endpoint Achieved in Interim Analysis
From pfizer.com
Pfizer Inc.
@pfizer
May 25, 2022
Today, we were joined by Rwanda, Ghana, Senegal, Malawi & Uganda as we launched a new initiative to help close the global health equity gap & enable sustained access to medicines and vaccines in 45 lower-income countries. More here: on.pfizer.com/3afNuKx #HealthEquity #WEF22
00:00
Pfizer Inc.
@pfizer
Nov 18, 2020
BREAKING: We are proud to announce, along with @BioNTech_Group, that the Phase 3 study of our #COVID19 vaccine candidate has met all primary efficacy endpoints.
BNT162b2 Meets Primary Efficacy Endpoints
From pfizer.com
Pfizer Inc.
@pfizer
May 3, 2021
Today we have announced we are mobilizing the largest humanitarian relief effort in our company’s history to help the people of India fight the vicious second wave of coronavirus that is currently ravaging the nation.
00:00
Pfizer Inc.
@pfizer
Sep 5, 2020
We now have more than 25,000 participants dosed in our #COVID19 vaccine clinical trial. Learn more about our progress in developing a potential #COVID19 vaccine, here: on.pfizer.com/3jOCfbn
Pfizer Inc.
@pfizer
Feb 14, 2022
Deep vein thrombosis (#DVT), a blood clot in a deep vein, can travel to the lungs, leading to a pulmonary embolism (#PE). Symptoms of PE include difficulty breathing and chest pain. Contact your doctor if experiencing symptoms—this is no time to wait.
Learn More
From notimetowait.com
Pfizer Inc.
@pfizer
Mar 31, 2021
Today, with @BioNTech_Group, we announced positive topline results in adolescents 12-15 years of age from the Phase 3 Pfizer-BioNTech #COVID19 vaccine study.
Breaking News
From pfizer.com
Pfizer Inc.
@pfizer
Nov 9, 2020
An update from @AlbertBourla on our investigational #COVID19 vaccine program with @BioNTech_Group.
Albert Bourla Discusses COVID-19 Vaccine Efficacy Results
From pfizer.com
Pfizer Inc.
@pfizer
May 7, 2021
BREAKING: Today, with @BioNTech_Group, we initiated the submission of a BLA for @FDA approval of the Pfizer-BioNTech #COVID19 vaccine to prevent COVID-19 in individuals 16 years and older.
Pfizer Inc.
@pfizer
Oct 7, 2021
UPDATE: We and @BioNTech_Group officially submitted our request to @US_FDA for Emergency Use Authorization (EUA) of our #COVID19 vaccine in children 5 to <12.
00:00
Pfizer Inc.
@pfizer
Apr 9, 2021
BREAKING: Today, with @BioNTech_Group, we submitted a request to US FDA to expand emergency use of our COVID-19 vaccine to adolescents 12 to 15 years of age.
Pfizer Inc.
@pfizer
May 3, 2021
Replying to @pfizer
We are donating enough of these medicines to ensure that every COVID-19 patient in every public hospital across India can have access to them in the next 90 days free of charge. This effort has the potential to impact the lives of hundreds of thousands of patients.
Pfizer Inc.
@pfizer
Nov 9, 2020
Replying to @pfizer
This is a first but critical step as we continue our work to try to deliver a safe and effective #COVID19 vaccine.
Pfizer Inc.
@pfizer
Nov 9, 2020
Replying to @pfizer
Efficacy in the majority of participants, safety data and consistent manufacturing are the three requirements that are needed before we are able to file for Emergency Use Authorization.